Header Logo

Connection

HUSSEIN TAWBI to Transcription Factors

Back to Details
This is a "connection" page, showing publications HUSSEIN TAWBI has written about Transcription Factors.
HUSSEIN TAWBI
Connection Strength
0.044
Transcription Factors
  1. A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors. Clin Cancer Res. 2014 Apr 01; 20(7):1900-9.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.